SITE011-0176

SITE011 (ITA) › SITE011-0176

SITE011-0176

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE011 (ITA) · Dr. Jansen
consented 2026-04-02

enrolled

AEs

3

Serious

0

Dropout signal

–

Adverse events

3

Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-12-31 (study day 84); relationship: not assessed

mild assessed

Grade 2 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-11-02 (study day 25); relationship: NOT RELATED

moderate assessed

Grade 2 Anaemia — outcome: UNKNOWN; onset 2022-10-29 (study day 21); relationship: not assessed

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.